Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pegaspargase
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oncaspar 3,750unit powder for solution for injection vials
0801050BABBACAB
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750units/5ml inj vials (Imported)
0801050BABBAAAA
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750units/5ml solution for injection vials
0801050BABBABAA
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Pegaspargase 3,750units inj vials
0801050BAAAABAB
|
Pegaspargase | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Pegaspargase 3,750units/5ml solution for injection vials
0801050BAAAAAAA
|
Pegaspargase | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.